Second-Course Pembrolizumab in NSCLC
Results of a Pooled Outcomes Analysis of Phase III Trials Using a Second Course of Pembrolizumab in Advanced NSCLC

Released: August 16, 2022

Expiration: August 15, 2023

Activity

Progress
1
Course Completed